Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose

WorldPharmaNewsJanuary 10, 2022

Tag: COVID-19 , Omicron , Monoclonal Antibodies

PharmaSources Customer Service